BVMF/I1DX34 (BVMF/I1DX34)

Brazil Stock Exchange: BVMF/I1DX34 · BRL

R$600

-15.76 (-2.6%)· Recorded snapshot

Market cap	238.3B
Revenue (ttm)	23.6B
Net income (ttm)	5.9B
EPS (ttm)	R$15.2
P/E (trailing)	39.5x
P/E (forward)	35.9x
Volume	18
Beta	1.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 23.6B
Net income (ttm): 5.9B
EPS (ttm): R$15.2
P/E (trailing): 39.5x
P/E (forward): 35.9x
Market cap: 238.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E35.9

P25 n/aP50 n/aP75 n/a

Trailing P/E39.5

P25 n/aP50 n/aP75 n/a

ROE74.2

P25 n/aP50 n/aP75 n/a

ROIC47.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/I1DX34 indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-02
Employees	11,000
Employees change	0
Employees growth	0%
Enterprise value	BRL 243.1B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1983
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	BRI1DXBDR001
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	BRL 238.3B
Next earnings date	2026-11-02
Price	BRL 600.24
Price currency	BRL
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-27
Symbol	bvmf/I1DX34
Website	https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	53.29x
Average P/E ratio (3Y)	45.32x
Average P/E ratio (5Y)	49.9x
Earnings yield	2.53%
EV/Earnings	41.17x
EV/EBIT	30.83x
EV/EBITDA	27.22x
EV/FCF	37.41x
EV/Sales	9.94x
FCF / EV yield	2.67%
FCF yield	2.73%
Forward P/E	35.93x
Graham number	83.92318
Graham upside	-86.02%
Lynch fair value	BRL 139.55
Lynch upside	-76.75%
P/(FCF - SBC) ratio	38.6x
P/(OCF - SBC) ratio	35.15x
P/B ratio	28.52x
P/E ratio	39.47x
P/FCF ratio	36.67x
P/OCF ratio	33.53x
P/S ratio	10.1x
Price / tangible book value	41.68x
Price/EBITDA ratio	28.36x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.23%
EBITDA margin	35.62%
Effective tax rate	19.99%
FCF margin	26.69%
Gross margin	62.45%
Operating margin	32.23%
Pretax margin	31.28%
Profit margin	25.03%
Profit per employee	BRL 536,757
Profitable quarters	110
Profitable years	27
Revenue per employee	BRL 2.1M
ROA	27.09%
ROA (5Y)	23.48%
ROCE	68.11%
ROE	74.21%
ROE (5Y)	84.36%
ROIC	47.23%
ROIC (5Y)	45.43%
SBC / revenue	1.38%
Tax / revenue	6.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	18.41%
EPS growth (Q)	17.63%
EPS growth (QoQ)	23.05%
EPS growth 10Y	20.49%
EPS growth 3Y	14.67%
EPS growth 5Y	11.14%
EPS growth quarters	8
EPS growth years	3
FCF growth	59.92%
FCF growth (Q)	112.68%
FCF growth (QoQ)	37.67%
FCF growth 3Y	28.38%
FCF growth 5Y	12.56%
Gross profit growth	14.43%
Gross profit growth (Q)	12.14%
Gross profit growth 3Y	10.5%
Gross profit growth 5Y	9.67%
Net income growth	15.62%
Net income growth (Q)	15.11%
Net income growth (QoQ)	21.54%
Net income growth 3Y	12.92%
Net income growth 5Y	9.38%
Net income growth quarters	8
Net income growth years	3
OCF growth	51.41%
OCF growth (Q)	86.9%
OCF growth (QoQ)	30.39%
OCF growth 10Y	16.86%
OCF growth 3Y	22.47%
OCF growth 5Y	12.23%
Operating income growth	17.77%
Operating income growth (Q)	14.08%
Operating income growth 3Y	11.88%
Operating income growth 5Y	11.18%
Revenue growth	12.77%
Revenue growth (Q)	9.66%
Revenue growth (QoQ)	6.64%
Revenue growth 10Y	10.42%
Revenue growth 3Y	9.02%
Revenue growth 5Y	8.37%
Revenue growth quarters	46
Revenue growth years	28

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -607.1M
Depreciation and amortization	BRL 823.8M
EBIT	BRL 7.6B
EBITDA	BRL 8.4B
EPS	BRL 15.21
Financing cash flow	BRL -6.2B
Free cash flow	BRL 6.5B
Free cash flow minus SBC	BRL 6.2B
Gross profit	BRL 14.7B
Income taxes	BRL 1.5B
Investing cash flow	BRL -684.1M
Net borrowing	BRL -721.8M
Net cash flow	BRL 167.5M
Net income	BRL 5.9B
Operating cash flow minus SBC	BRL 6.8B
Operating income	BRL 7.6B
Revenue	BRL 23.6B
Stock-based compensation	BRL 326.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	21.94
Book value per share	BRL 105.92
Debt / EBITDA	0.66
Debt / equity	0.68
Debt / FCF	0.87
Goodwill	BRL 2.2B
Interest coverage	38.84
Long-term assets	BRL 9.8B
Long-term liabilities	BRL 2.6B
Net cash (debt)	BRL -4.7B
Net cash / market cap	-1.96%
Net debt / EBITDA	0.55
Net debt / equity	0.56
Net debt / FCF	0.72
Piotroski F-Score	8
Property, plant and equipment	BRL 4.6B
Shareholders' equity	BRL 8.4B
Tangible book value	BRL 5.7B
Tangible book value per share	BRL 72.48
Total assets	BRL 17.8B
Total cash	BRL 1B
Total debt	BRL 5.7B
Total liabilities	BRL 9.5B
WACC	12.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.34
Current assets	BRL 8.1B
Current liabilities	BRL 6.9B
Current ratio	1.17
Inventory turnover	4.36
Net working capital	BRL 3.7B
Quick ratio	0.73
Working capital	BRL 1.1B
Working capital turnover	130.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.4%
Shareholder yield	2.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 616.37
1D price change	-2.56%
1M price change	11.55%
1M total return	11.55%
1W price change	9.85%
1W total return	9.85%
1Y price change	-13.53%
1Y return CAGR	-13.54%
1Y total return	-13.53%
20-day SMA	BRL 556.98
200-day SMA	BRL 591.72
3M price change	4.57%
3M total return	4.57%
3Y price change	36.05%
3Y return CAGR	10.81%
3Y total return	36.05%
50-day SMA	BRL 561.34
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 813.60
52-week high date	2025-11-24
52-week low	BRL 509.99
52-week low date	2026-10-07
5Y price change	-14%
5Y return CAGR	-2.97%
5Y total return	-14%
6M price change	5.86%
6M total return	5.86%
All-time high	BRL 813.60
All-time high date	2025-11-24
All-time low	BRL 225.06
All-time low date	2020-02-28
Average true range (ATR)	BRL 15.82
Average volume	24.5
Beta (5Y)	1.55
Change from 52-week high	-26.22%
Change from 52-week low	17.7%
Change from all-time high	-26.22%
Change from all-time low	166.71%
Change from open	0%
Day's gap	-2.56%
Dollar volume	BRL 10,804
High price	BRL 600.24
Low price	BRL 600.24
Monthly RSI	51.56
Open price	BRL 600.24
Previous close	BRL 616.00
Price vs 150-day SMA	-2.62%
Price vs 20-day SMA	7.77%
Price vs 200-day SMA	1.44%
Price vs 50-day SMA	6.93%
Relative volume	0.73
RSI	59.71
Sharpe ratio	0.68
Sortino ratio	1.33
Volume	18
Weekly RSI	51.25
YTD price change	-20.53%
YTD total return	-20.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78.5M
Shares change (QoQ)	-1.06%
Shares change (YoY)	-2.4%
Shares held by insiders	0.26%
Shares held by institutions	96.66%
Short ratio	3.5 days

Deeper analysis on BVMF/I1DX34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/I1DX34 report

Is a complete BVMF/I1DX34 research report available?

No complete published report is available for bvmf/I1DX34 (BVMF/I1DX34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/I1DX34 (BVMF/I1DX34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/I1DX34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/I1DX34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/I1DX34

Frequently asked questions